Bendamustine in combination with rituximab for the first-line treatment of indolent non-Hodgkin's lymphoma
Riemsma R, et al.
Record ID 32013000879
English
Details
Project Status:
Completed
URL for project:
https://www.journalslibrary.nihr.ac.uk/programmes/hta/108701/#/
Year Published:
2013
URL for published report:
n/a
Requestor:
NIHR Health Technology Assessment programme
URL for additional information:
https://www.nice.org.uk/guidance/indevelopment/gid-tag278
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England, United Kingdom
MeSH Terms
- Rituximab
- Bendamustine Hydrochloride
- Lymphoma, Non-Hodgkin
- Antineoplastic Agents, Alkylating
- Antineoplastic Combined Chemotherapy Protocols
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.